Blog

LongeVC Portfolio Company PreComb Wins 2025 RISE Award in the Healthcare Category

Precision oncology advanced last night as our portfolio company PreComb was named the winner of the 2025 RISE Award in the Healthcare category.

Organized by Sustainable Times, the Responsible Investment, Sustainability, and ESG (RISE) Awards recognize pioneering organizations driving positive change across industries. PreComb was honored for its transformative work in personalizing cancer treatment.

PreComb's platform creates miniature 3D replicas of patients' tumors and tests different treatments in the lab before any medication is administered. This approach helps clinicians identify the most effective therapy for each patient, reducing reliance on trial-and-error protocols. For cancer patients, this means faster treatment decisions, fewer toxic interventions, and clearer pathways to therapies most likely to succeed.

We're proud to support CEO Oliver Mauti, CSO Jens M. Kelm, and the entire PreComb team as they continue scaling their impact in precision oncology.

Congratulations to PreComb and all the RISE Award winners advancing healthcare and sustainable investment.

More information about the awards here.
Partner News